Lopes Rodrigues V, Di Luca A, Mleczko J, Meleady P, Henry M, Pesic M, et al. Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles. Sci Rep. 2017;7:44541 pubmed publisher

Seebacher N, Richardson D, Jansson P. A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC. Cell Death Dis. 2016;7:e2510 pubmed publisher

Jansson P, Yamagishi T, Arvind A, Seebacher N, Gutierrez E, Stacy A, et al. Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp). J Biol Chem. 2015;290:9588-603 pubmed publisher

Katt M, Mayo L, Ellis S, Mahairaki V, Rothstein J, Cheng L, et al. The role of mutations associated with familial neurodegenerative disorders on blood-brain barrier function in an iPSC model. Fluids Barriers CNS. 2019;16:20 pubmed publisher

Ji N, Yang Y, Cai C, Wang J, Lei Z, Wu Z, et al. Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study. Front Oncol. 2019;9:514 pubmed publisher

De Vera A, Gupta P, Lei Z, Liao D, Narayanan S, Teng Q, et al. Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo. Cancer Lett. 2019;442:91-103 pubmed publisher

Ji N, Yang Y, Cai C, Lei Z, Wang J, Gupta P, et al. VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters. Front Pharmacol. 2018;9:1236 pubmed publisher

Wang H, Gao Z, Liu X, Agarwal P, Zhao S, Conroy D, et al. Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance. Nat Commun. 2018;9:562 pubmed publisher

Al Akra L, Bae D, Sahni S, Huang M, Park K, Lane D, et al. Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones. J Biol Chem. 2018;293:3562-3587 pubmed publisher

Inci F, Celik U, Turken B, Özer H, Kok F. Construction of P-glycoprotein incorporated tethered lipid bilayer membranes. Biochem Biophys Rep. 2015;2:115-122 pubmed publisher

Wang C, Huang C, Chou P, Chang Y, Wei S, Guengerich F, et al. 7-ketocholesterol and 27-hydroxycholesterol decreased doxorubicin sensitivity in breast cancer cells: estrogenic activity and mTOR pathway. Oncotarget. 2017;8:66033-66050 pubmed publisher

Lopes Rodrigues V, Oliveira A, Correia da Silva M, Pinto M, Lima R, Sousa E, et al. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells. Bioorg Med Chem. 2017;25:581-596 pubmed publisher

Ma J, Zhang Y, Tang K, Zhang H, Yin X, Li Y, et al. Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles. Cell Res. 2016;26:713-27 pubmed publisher

Zhang Y, Zhang G, Wang Y, Patel B, Talele T, Yang D, et al. Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters. Sci Rep. 2016;6:25694 pubmed publisher

Wang Y, Huang Y, Anreddy N, Zhang G, Zhang Y, Xie M, et al. Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicin. Oncotarget. 2016;7:5877-91 pubmed publisher

Seebacher N, Lane D, Jansson P, Richardson D. Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter. J Biol Chem. 2016;291:3796-820 pubmed publisher

Giuliano S, Cormerais Y, Dufies M, Grepin R, Colosetti P, Belaid A, et al. Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux. Autophagy. 2015;11:1891-904 pubmed publisher

Zhang Y, Zhang H, Zhang G, Wang Y, Kathawala R, Si R, et al. Semi-synthetic ocotillol analogues as selective ABCB1-mediated drug resistance reversal agents. Oncotarget. 2015;6:24277-90 pubmed

Ween M, Armstrong M, Oehler M, Ricciardelli C. The role of ABC transporters in ovarian cancer progression and chemoresistance. Crit Rev Oncol Hematol. 2015;96:220-56 pubmed publisher

Seebacher N, Richardson D, Jansson P. Glucose modulation induces reactive oxygen species and increases P-glycoprotein-mediated multidrug resistance to chemotherapeutics. Br J Pharmacol. 2015;172:2557-72 pubmed publisher

Kadova Z, Dolezelova E, Cermanova J, Hroch M, Laho T, Muchova L, et al. IL-1 receptor blockade alleviates endotoxin-mediated impairment of renal drug excretory functions in rats. Am J Physiol Renal Physiol. 2015;308:F388-99 pubmed publisher

Wang Y, Kathawala R, Zhang Y, Patel A, Kumar P, Shukla S, et al. Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1. Biochem Pharmacol. 2014;90:367-78 pubmed publisher

Dessilly G, Elens L, Panin N, Capron A, Decottignies A, Demoulin J, et al. ABCB1 1199G>A genetic polymorphism (Rs2229109) influences the intracellular accumulation of tacrolimus in HEK293 and K562 recombinant cell lines. PLoS ONE. 2014;9:e91555 pubmed publisher

Ma Q, Zhang Y, Shi J, Li G. Clinical significance of P-glycoprotein and glutathione S-transferase ? expression in gallbladder carcinoma. Exp Ther Med. 2014;7:635-639 pubmed

Yamagishi T, Sahni S, Sharp D, Arvind A, Jansson P, Richardson D. P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration. J Biol Chem. 2013;288:31761-71 pubmed publisher

Yosef N, Ubogu E. An immortalized human blood-nerve barrier endothelial cell line for in vitro permeability studies. Cell Mol Neurobiol. 2013;33:175-86 pubmed publisher

Su C. Tanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of P-gp and LC3-II. Exp Ther Med. 2012;3:555-559 pubmed

Ferreira P, Ruela de Sousa R, Queiroz K, Souza A, Milani R, Pilli R, et al. Knocking down low molecular weight protein tyrosine phosphatase (LMW-PTP) reverts chemoresistance through inactivation of Src and Bcr-Abl proteins. PLoS ONE. 2012;7:e44312 pubmed publisher

Mason C, Buhimschi I, Buhimschi C, Dong Y, Weiner C, Swaan P. ATP-binding cassette transporter expression in human placenta as a function of pregnancy condition. Drug Metab Dispos. 2011;39:1000-7 pubmed publisher

Abraham I, Jain S, Wu C, Khanfar M, Kuang Y, Dai C, et al. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells. Biochem Pharmacol. 2010;80:1497-506 pubmed publisher

Shen T, Kuang Y, Ashby C, Lei Y, Chen A, Zhou Y, et al. Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10). PLoS ONE. 2009;4:e7520 pubmed publisher

Kuang Y, Shen T, Chen X, Sodani K, Hopper Borge E, Tiwari A, et al. Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance. Biochem Pharmacol. 2010;79:154-61 pubmed publisher

Zhou Y, Hopper Borge E, Shen T, Huang X, Shi Z, Kuang Y, et al. Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance. Biochem Pharmacol. 2009;77:993-1001 pubmed publisher

Shi Z, Tiwari A, Shukla S, Robey R, Kim I, Parmar S, et al. Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478. Biochem Pharmacol. 2009;77:781-93 pubmed publisher

Lemaire S, Van Bambeke F, Mingeot Leclercq M, Tulkens P. Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells. Antimicrob Agents Chemother. 2007;51:2748-57 pubmed

Azzariti A, Colabufo N, Berardi F, Porcelli L, Niso M, Simone G, et al. Cyclohexylpiperazine derivative PB28, a sigma2 agonist and sigma1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer. Mol Cancer Ther. 2006;5:1807-16 pubmed

Leitch G, Scanlon M, Shaw A, Visvesvara G. Role of P glycoprotein in the course and treatment of Encephalitozoon microsporidiosis. Antimicrob Agents Chemother. 2001;45:73-8 pubmed

Chu T, Lin T, Kawinski E. Detection of soluble P-glycoprotein in culture media and extracellular fluids. Biochem Biophys Res Commun. 1994;203:506-12 pubmed

Chu T, Kawinski E, Lin T. Characterization of a new monoclonal antibody F4 detecting cell surface epitope and P-glycoprotein in drug-resistant human tumor cell lines. Hybridoma. 1993;12:417-29 pubmed